In a filing, HCA Healthcare Inc revealed its SVP & Chief Human Res. Officer Berres Jennifer unloaded Company’s shares for reported $3.08 million on Feb 14 ’25. In the deal valued at $322.59 per share,9,533 shares were sold. As a result of this transaction, Berres Jennifer now holds 15,412 shares worth roughly $4.99 million.
Then, Berres Jennifer bought 9,533 shares, generating $3,075,238 in total proceeds.
Before that, Reiner Deborah M bought 3,510 shares. HCA Healthcare Inc shares valued at $1,131,589 were divested by the Former Officer at a price of $322.39 per share.
A number of analysts have revised their coverage, including Wells Fargo’s analysts, who decreased its forecast for the stock in late November from “an Equal weight” to “an Underweight”. Raymond James also remained covering HCA and has decreased its forecast on November 22, 2024 with a “Mkt perform” recommendation from previously “an Outperform” rating. KeyBanc Capital Markets started covering the stock on October 11, 2024. It rated HCA as “an Overweight”.
Price Performance Review of HCA
On Tuesday, HCA Healthcare Inc [NYSE:HCA] saw its stock fall -3.75% to $323.55. Over the last five days, the stock has gained 3.69%. HCA Healthcare Inc shares have risen nearly 7.80% since the year began. Nevertheless, the stocks have fallen -0.34% over the past one year. While a 52-week high of $417.14 was reached on 03/10/25, a 52-week low of $289.98 was recorded on 01/03/25. SMA at 50 days reached $317.23, while 200 days put it at $345.70.
Levels Of Support And Resistance For HCA Stock
The 24-hour chart illustrates a support level at 315.13, which if violated will result in even more drops to 306.71. On the upside, there is a resistance level at 335.46. A further resistance level may holdings at 347.37. The Relative Strength Index (RSI) on the 14-day chart is 51.43, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 9.08, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 44.69%. Stochastics %K at 74.91% indicates the stock is a holding.
The most recent change occurred on September 03, 2024 when Morgan Stanley began covering the stock and recommended ‘”an Equal-weight”‘ rating along with a $427 price target.
